Characteristics of Immune Checkpoint Inhibitor-Associated Gastritis: Report from a Major Tertiary Care Center

BACKGROUND: Immune checkpoint inhibitors (ICIs) have increased our ability to treat an ever-expanding number of cancers. We describe a case series of 25 patients who were diagnosed with gastritis following ICI therapy. MATERIALS AND METHODS: This was a retrospective study involving 1712 patients tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Farha, Natalie, Faisal, Muhammad Salman, Allende, Daniela S, Sleiman, Joseph, Shah, Ravi, Farha, Nicole, Funchain, Pauline, Philpott, Jessica R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Immuno-Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400162/
https://www.ncbi.nlm.nih.gov/pubmed/36905577
http://dx.doi.org/10.1093/oncolo/oyad031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400162/
https://www.ncbi.nlm.nih.gov/pubmed/36905577
http://dx.doi.org/10.1093/oncolo/oyad031

Ejemplares similares